Trifluoromescaline
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
JSmol) | |
| |
| |
Trifluoromescaline (TF-M) is a
methoxy group of mescaline. Synthesis of this compound was first reported by Daniel Trachsel in 2011, alongside many other related compounds.[1][2] Trifluoromescaline was found to be one of the most potent compounds in the series, with a reported dosage of 15โ40 mg (and 60 mg being described as a "strong overdose"), and a slow onset of action and long duration of effects, lasting 14โ24 hours or more.[3]